Expanding from oncology into neurodegeneration, company leverages tiny extracellular vesicles to enhance blood-based biomarker discovery. Precision medicine biotech FYR Bio…
Until Labs targets organ transplantation bottlenecks as a first step towards whole-body reversible cryopreservation. Cryonics startup Until Labs has closed…
Bio Protocol’s first longevity-focused initiative, Aubrai, raised more than $900,000 in research funding within weeks. Decentralized science company Bio Protocol…
